March 18, 2026 05:00 ET | Source: Boehringer Ingelheim Limited World Parasite Awareness Day, held annually on March 20, is an important reminder that parasites such as fleas, ticks and worms are among the most common health threats for pets around the world, yet they can easily be prevented. A global survey among 6,500 pet owners1 shows […]
March 17, 2026 17:02 ET | Source: Zymeworks Inc. VANCOUVER, British Columbia , March 17, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the acceptance of an oral presentation and six abstracts from its wholly-owned R&D
March 17, 2026 16:35 ET | Source: Adagene Inc. SAN DIEGO and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that muzastotug will be highlighted in two poster presentations at this year’s AACR Meeting, taking place
New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 12 assays specific to brain and peripheral Tau isoforms | NULISA™ data to be presented in over 11 scientific sessions and 25 posters at the International Conference on
March 17, 2026 09:03 ET | Source: SK pharmteco Inc. RANCHO CORDOVA, Calif., March 17, 2026 (GLOBE NEWSWIRE) — SK pharmteco today announced the successful conclusion of a regulatory inspection of its small molecule North America facility in La Porte, Texas. The U.S. Food and Drug Administration (FDA) carried out a general inspection of the site from February 9
Imprivata Enterprise Access Management now offers facial recognition, AI-powered behavioral analytics, and high-assurance identity verification to further streamline clinical access, improve operational efficiency, and strengthen security posture March 16, 2026 18:00 ET | Source: Imprivata MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) — Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today introduced
March 13, 2026 09:54 ET | Source: Junshi Biosciences SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2025 and provided corporate updates. FINANCIAL
UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026 March 12, 2026 09:00 ET | Source: PROCEPT BioRobotics SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) — PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation platform for delivering Aquablation therapy
March 12, 2026 04:04 ET | Source: SK pharmteco Inc. RANCHO CORDOVA, Calif., March 12, 2026 (GLOBE NEWSWIRE) — SK pharmteco today announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France. This state-of-the-art plant is now fully operational and prepared to support late-stage and commercial viral vector programs at scale. Recently, the facility was inspected by
March 11, 2026 11:00 ET | Source: Royal Philips March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare
March 11, 2026 11:10 ET | Source: Io Therapeutics, Inc. SPRING, Texas, March 11, 2026 (GLOBE NEWSWIRE) — Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of Texas MD Anderson Cancer Center demonstrating effectiveness of the retinoid X receptor (RXR) agonist compound IRX4204 in models of
March 11, 2026 09:32 ET | Source: TekniPlex Wayne, PA, March 11, 2026 (GLOBE NEWSWIRE) — TekniPlex Healthcare, a global leader in advanced materials science and precision manufacturing for the medical and healthcare industries, announced its participation at the China International Medical Equipment Fair (CMEF) 2026. TekniPlex will highlight its global capabilities in medical materials and precision
March 10, 2026 11:00 ET | Source: Royal Philips March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and
March 10, 2026 09:00 ET | Source: Egg Medical, Inc. WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) — Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that
March 09, 2026 10:18 ET | Source: Menarini FLORENCE, Italy, March 09, 2026 (GLOBE NEWSWIRE) — 2025 was a “positive year” for Menarini, which is celebrating its 140th anniversary this year, despite considerable global “turbulence”. Lucia Aleotti, shareholder and member of the Menarini Board, said so with a smile as she opened the company’s customary annual meeting
